the prevalence of ms has increased in canada at an average rate of 1.5 per cent per year since 2011. according to
health canada, this increase in prevalence rates is primarily due to people being diagnosed earlier in their disease progression and therapies that lead to a longer life expectancy for those living with ms.
the average life expectancy for someone living with ms is roughly five to ten years shorter than that of those in the general population, with people living to an average of 76 years of age. life expectancy rates continue to increase for people with ms due to better treatments available. according to
ms canada, only roughly 44 per cent of people with ms die from their disease or complications of their disease.
impact of multiple sclerosis on canadian society
ms has a significant impact on canadian society as well as those who have the disease. in total, the annual cost of ms in canada is approximately
$3.4 billion, representing the combined expenses of direct health costs, productivity loss, and other related costs associated with living with a chronic disease.
when broken down by person, the average cost faced by canadian society when someone is diagnosed with ms is roughly
$42,880 per year.
delayed diagnosis also affects direct health costs, productivity loss and other related costs. between 2020 and 2024, delayed diagnosis led to an additional $578.2 million total expenditure cost for ms.
in terms of the healthcare system, which encompasses inpatient and outpatient care, emergency visits, consultations with specialists, rehabilitation services, pharmaceuticals, and comorbidity care, the annual cost is approximately $1,311.80 per person with ms.
productivity loss, which makes up reduced employment, absenteeism, premature mortality, and informal care, accounts for $1,332.20 per person per year, and other costs, including aids and home modifications, formal care, long-term care, support payments, and efficiency losses amounted to
$787.50 per year per person with ms.